A morbillivirus causing mass mortality in seals. by Osterhaus, A.D.M.E. (Albert)
Comment 
A morbillivirus causing mass mortality 
in seals 
During an outbreak of a serious apparently infectious disease among harbour seals (Phoca 
vitulina), which started in the Kattegat area in April 1988 and rapidly spread to the 
North sea, the Wadden sea and the Baltic sea, > 17 000 animals died within a period of 
eight months. In August 1988 it was realized that the clinical symptoms and pathological 
lesions were similar to those found in canine distemperS: apart from general depression 
and fever, the animals suffered from severe respiratory, gastrointestinal nd central 
nervous disease and a variety of viral, bacterial and parasitic infections were frequently 
encountered, suggesting a severe malfunctioning of the immune system. At different expert 
meetings, held in several of the countries involved, possible explanations for the deaths 
were not only attributed to an infectious agent, but also to effects of overpopulation and 
environmental pollution. Seroepizootiologicai studies and the failure of vaccination 
experiments suggested that a herpesvirus and a picornavirus, which had been isolated 
from dead seals at the beginning of the outbreak 2, were opportunistic nfections occurring 
in animals suffering from another infection ~ rather than being the primary cause of the 
outbreaks. Serological studies were then extended to other viruses of carnivores, known 
to cause similar symptoms. Screening of a large panel of seal sera from The Netherlands, 
Denmark, FRG, Sweden and the UK, collected before and during the outbreak, in a virus 
neutralization test for the presence of canine distemper virus (CDV) neutralizing 
antibodies, indicated that CD V or a closely related morbillivirus was the primary cause 
of the disease outbreak I . The initial failure to isolate the virus from organs of affected 
animals may be explained by the fact that no isolation procedures were used which favour 
the isolation of morbilliviruses ~.We isolated the virus directly in cell cultures and after 
passage through SPF dogs, which developed CD V-neutralizing antibodies and mild clinical 
signs suggestive of CD V infection. The presence of morbillivirus in infected cells was 
shown by immunofluorescence with CD V-specific antibodies howing syncytia formation 
and by negative contrast electron microscopy 4.
To study further where and when 
the morbillivirus infection had been 
introduced into the seal populations, 
the serological studies were extended 
to samples collected in other areas of 
the world between 1984 and 1988. All 
samples proved to be negative in 
the CDV-neutralization assay. As 
the humoral immune response after 
natural morbillivirus infection persists 
for several years and perhaps even 
for life - as, for example, in the dog 
after CDV infection - and assuming 
that this also holds true for the 
morbillivirus infection of seals, we 
concluded that the morbillivirus in- 
volved in the outbreak does not 
commonly infect pinnipeds 1'4. The 
first confirmation of our findings 
came from the work of Kennedy 
et al., who also demonstrated the 
presence of morbillivirus antigen in 
organs of infected harbour seals and 
isolated the virus from organs of an 
affected seal 5. 
Further evidence for a morbillivirus 
as the primary cause of the outbreak 
came from the work by Mahy et al., 
who showed by nucleic acid hybrid- 
ization studies, that the virus was 
similar to both CDV and rinderpest 
virus (RPV), but should probably be 
considered a new member of the 
genus Morbillivirus 6. This could also 
be concluded from the results obtained 
by Cosby et al. with a panel of 
monoclonal ntibodies, raised against 
CDV or RPV 7. Final proof that the 
primary cause of the outbreak was 
indeed the newly identified morbiUi- 
virus, now christened phocid distemper 
virus (PDV), came from the evaluation 
of the efficacy of two inactivated 
CDV vaccines in protecting seals 
against experimental PDV infection a.
Indeed we showed that seronegative 
seals were protected from fatal chal- 
lenge with organ material from dead 
seals, by vaccination with these vac- 
cines. This experiment ot only pro- 
vided final proof for the causative 
role of the morbillivirus for the 
outbreak, by fulfilling the last of 
Koch's postulates, but also provided 
a useful tool to protect seals in 
sanctuaries and other places where 
seals are kept in captivity. 
The origin of PDV is not known 
at present. In a recent serological 
study among seals in Greenland, it
was shown that morbillivirus-specific 
antibodies were present in these seals 
before the beginning of the outbreak 
in the seals of north-western Europe 9. 
In collaboration with a Siberian 
group, we recently demonstrated the 
presence of CDV-neutralizing anti- 
bodies in the sera of Lake Baikal seals 
(Phoca sibirica), during ~tnd after 
an outbreak of a distemper-like 
disease, that occurred in the year 
before the outbreak in north-western 
Europe 1°'11. The virus was isolated 
and further biological and molecular 
biological characterization f viruses 
isolated during both outbreaks are 
being conducted at present in order 
to conclude whether an epizootio- 
logical link is likely to have existed 
between both the outbreaks. Our 
recent finding that morbillivirus- 
specific antibodies, not neutralizing 
CDV, could be demonstrated with an 
enzyme-linked immunosorbent assay 
in sera from seals in north-western 
Europe before the outbreak took 
place, may reflect the existence of 
antigenically different morbilliviruses 
in the seals of north-western Europe 12. 
The virus circulating in the recent 
outbreak is distinguished by having 
increased pathogenicity in harbour 
seals, which has enabled the identifi- 
cation of the seal distemper problem. 
It may not have been noticed had 
the virus only infected grey seals 
(Halichoerus gryphus), which show 
milder disease signs. The sudden 
appearance of a seal morbillivirus 
with altered biological properties 
could have been due to a mutation 
which altered the pathogenicity of 
a pre-existing non-pathogenic virus 
within the host species, or to a 
mutation that delayed the virus' 
host-species range. 
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Prospects for the total eradication 
of rinderpest 
Rinderpest, a major economic problem of Africa and Asia, is a highly contagious viral 
disease of cattle and buffalo with > 90% mortality in susceptible herds. We have developed 
an effective vaccinia virus recombinant vaccine for rinderpest which protects cattle against 
challenge by more than 1000 times the lethal dose of the virus. The vaccine circumvents 
the major logistical problems of the Plowright tissue culture vaccine that occasioned 
previous failures to eradicate rinderpest by vaccination. The recombinant can easily be 
propagated and administered by scarification, using methods employed in the world-wide 
eradication of smallpox. More importantly, the lyophilized form of vaccinia virus is 
thermostable and does not require maintenance of the cold chain, a distinct advantage 
in the hot and arid regions of Africa and Asia. 
Rinderpest isnot only the single most 
important disease of livestock in 
developing countries of Africa and 
Asia, but has also played a crucial 
role in the development of the 
veterinary profession. Now rinder- 
pest may enter a final chapter in its 
history as the focus of one of the first 
effective recombinant vaccines to find 
general use. While it took nearly 200 
years and a concerted international 
disease control campaign to eradicate 
smallpox using Jenner's vaccination 
technique, we could use vaccinia 
virus to rid the world of rinder- 
pest within a decade. To eradicate 
rinderpest using a vaccinia virus 
recombinant vaccine will clearly 
demonstrate he potential of this new 
generation of vaccines in controlling 
the major infectious diseases that in- 
flict economic hardship and suffering 
on humans and animals worldwide. 
An acute, febrile, highly con- 
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tagious viral disease of ruminants 
(particularly cattle and buffalo) with 
a rapid course and high mortality 
rate, rinderpest is characterized by 
inflammation, haemorrhaging, nec- 
rosis and erosion of the gastro- 
intestinal tract accompanied by 
bloody diarrhoea, wasting and death. 
It was first recognized as a distinct 
disease during the great European 
epizootic of 376-386 AD, and in the 
18th century alone, rinderpest wiped 
out an estimated 200 million cattle 
in Europe 1. Cattle from India intro- 
duced to Somalia in 1889 during the 
Italian invasion of Ethiopia kindled 
the most spectacular of recent epi- 
zootics. The disease quickly afflicted 
the entire cattle population of 
Ethiopia, the mortality rate exceed- 
ing 90%. The year 1889 is com- 
memorated on the Ethiopian calendar 
as 'Yekebit elkit', meaning 'the 
year of the annihilation of cattle'. 
Shortly thereafter, the disease en- 
gulfed the entire continent of Africa, 
killing hundreds of millions of cattle. 
The urgent need to combat rinder- 
pest resulted in the establishment of
the first veterinary school in Europe 
in 1762 and the convening of the First 
International Veterinary Congress at 
Hamburg in 1863. More recently, 
rinderpest was a major impetus for 
the founding of the Office Inter- 
nationale des Epizooties in Paris 1. In 
addition, the largest disease eradi- 
cation programme in the history 
of veterinary medicine, the Joint 
Program\15 (JP\15) to eradicate 
rinderpest, was initiated through 
the coordinated efforts of a number 
of governments and international 
organizations in 1962. During the 
execution of this programme, con- 
ducted in western Africa through 
1968, a total of 81 484 126 cattle were 
vaccinated occasioning a dramatic 
drop in the number, size and distri- 
bution of rinderpest outbreaks. After 
this successful campaign, the JP\15 
programme was extended to six 
countries in eastern Africa (Kenya, 
Tanzania, Uganda, Somalia, Ethiopia 
and the Sudan). Within 3 years a 
total of 124099454 cattle were 
vaccinated in those countries 2.
Because of failure to sustain sur- 
veillance, vaccination and control 
measures instituted uring the JP\15 
eradication programme, rinderpest is
again rampant in Africa. Many of the 
reasons for recrudescence of rinder- 
pest in Africa are related to problems 
in vaccine production, preservation 
and delivery. Developing countries 
do not have the technical resources 
to manufacture the Plowright tissue 
culture vaccine or to purchase this 
relatively expensive product from 
abroad. The arid, hot desert regions 
throughout much of Africa lack 
the reliable refrigeration facilities 
needed to keep tissue culture vaccine 
potent and efficacious. The con- 
tinuous movement of nomadic herds- 
men and their animals also makes it 
difficult to assemble cattle for vacci- 
nation. Many countries lack the 
financing to buy syringes and needles, 
distribute vaccine and monitor con- 
trol measures. A vaccinia virus 
recombinant vaccine for rinderpest 
could overcome most of these draw- 
backs to traditional vaccine pro- 
grammes in developing countries. 
Elaborate and advanced molecular 
biology techniques and facilities have 
been used to construct a very effective 
rinderpest vaccinia virus recombinant 
